Dr. Khosro Farhad, MD

Dr. Farhad practices at Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham.

Dr. Farhad's NPI, 1609069111, was assigned on August 20, 2007. Dr. Farhad graduated from Iran University of Medical Sciences in 1997. Dr. Farhad's New Hampshire license number on file is 16005.

Dr. Farhad's primary practice is Wentworth-Douglass Hospital, at 789 Central Ave, Dover, NH 03820 in Strafford County. The practice phone is (603) 740-2580.

Dr. Farhad's primary practice is Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham. Dr. Farhad is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Farhad to 3 more hospitals, 3 group practices and clinics, 3 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farhad practices, 9 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Farhad's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Farhad is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Farhad's licenses on file in 4 states: New Hampshire, Massachusetts, Washington and New Jersey.

Dmand AI lists carpal tunnel syndrome, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, hypersomnia, lower back pain, migraine and chronic headache and multiple sclerosis among the conditions Dr. Farhad treats.

CMS data shows 846 Medicare services from Dr. Farhad across 12 procedure codes in 2024, for 607 Medicare patients. Medicare paid $76,093 for them. Every service was in an office.

CMS counts 607 Medicare patients who saw Dr. Farhad in 2024. The largest group is under 65, with 213 patients. 61% of them have high cholesterol, and 57% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farhad's median patient age at 56, with 74% women.

In 2024, Dr. Farhad wrote 5,606 Medicare Part D claims for 739 patients. 75% of them were for generic drugs. CMS names the drug for 5,314 of them, across 92 drugs with 11 or more claims each, at $11,283,370 in total drug cost. In 2023, CMS named 5,133 claims across 85 drugs.

Dr. Farhad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farhad as offering telehealth. CMS counts 28 procedures of skin biopsy by Dr. Farhad, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Farhad, published from 2012 to 2023.

CMS Open Payments shows 12 general payments to Dr. Farhad from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 86% of the total. Grifols Shared Services North America, Inc. paid the most, $121.

Dmand AI lists 1 award for Dr. Farhad, most recently CMS Stage 1 EHR in 2013.

Dr. Farhad graduated from Iran University of Medical Sciences in 1997. Dr. Farhad is a member of AAN, AANEM and Peripheral Neuropathy Society.

Dr. Farhad is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.